论文期刊

取消

高级检索

检索历史清除

首页> Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico> Systematic review and meta-analysis efficacy and safety of immune checkpoint inhibitors in advanced melanoma patients with anti-PD-1 progression: a systematic review and meta-analysis.

Systematic review and meta-analysis efficacy and safety of immune checkpoint inhibitors in advanced melanoma patients with anti-PD-1 progression: a systematic review and meta-analysis.

导出 LinkOut

翻译打印收藏纠错

作者： N N,Alrabadi ^[1] ; H M,Abushukair ^[2] ; O E,Ababneh ^[2] ; S S,Syaj ^[2] ; S S,Al-Horani ^[2] ; A A,Qarqash ^[2] ; O A,Darabseh ^[2] ; M M,Al-Sous ^[2] ; S R,Al-Aomar ^[2] ; Y B,Ahmed ^[2] ; R,Haddad ^[3] ; F A,Al Qarqaz ^[4]

作者单位： Department of Pharmacology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan. nnalrabadi@just.edu.jo. ^[1] Facullty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan. ^[2] Department of Pharmaceutical Technology, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, 22110, Jordan. ^[3] Department of Dermatology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan. ^[4]

关键词 Anti-CTLA-4 Anti-PD-1 Cancer progression Immune Checkpoint Inhibitors Immunotherapy Melanoma

主题词老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);疾病恶化(Disease Progression);女(雌)性(Female);人类(Humans);男(雄)性(Male);黑色素瘤(Melanoma);中年人(Middle Aged);随机对照试验(主题)(Randomized Controlled Trials as Topic);再治疗(Retreatment);回顾性研究(Retrospective Studies);皮肤肿瘤(Skin Neoplasms)

DOI 10.1007/s12094-021-02598-6

PMID 33877531

发布时间 2021-12-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览3

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Clinical & translational oncology

2021年23卷9期

1885-1904页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷